Safety,Tolerability and MTD KA2507 (HDAC6 Inhibitor) in Patients With Solid Tumours

Clinical trial NCT03008018 · COMPLETED

Trial details

NCT number: NCT03008018
Sponsor: Karus Therapeutics Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2017-08-07
Primary completion: 2020-06-10
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.